United States: FDA Publishes Final Guidance On Reporting Listed Drug Amounts - Arnold & Porter

On Feb. 6, 2024, the U.S. FDA issued a final guidance, Reporting Amount of Listed Drugs and Biological Products Under Section 510(j)(3) of the FD&C Act.